|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 150.90 BDT | +2.58% |
|
+1.96% | +47.80% |
| 06-26 | Beximco suspension lifted; M1 payment date extension | AN |
| 06-24 | Beximco Pharmaceuticals PLC. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2026 | CI |
| Market Cap | 67.32B 544M 473M 440M 404M 763M 51.95B 775M 5.19B 2.04B 25.86B 2.04B 2B 86.72B | P/E 2026 * |
7.77x | P/E 2027 * | 7.06x |
|---|---|---|---|---|---|
| Enterprise Value | 67.32B 544M 473M 440M 404M 763M 51.95B 775M 5.19B 2.04B 25.86B 2.04B 2B 86.72B | EV / Sales 2026 * |
1.23x | EV / Sales 2027 * | 1.1x |
| Free-Float |
85.91% | Yield 2026 * |
3.99% | Yield 2027 * | 5.1% |
| 1 day | +2.58% | ||
| 1 week | +1.96% | ||
| 1 month | +3.85% | ||
| 3 months | +31.45% | ||
| 6 months | +30.99% | ||
| Current year | +47.80% |
| 1 week | 146.6 |  | 151.8 |
| 1 month | 145.3 | | 158.5 |
| Current year | 99.5 | | 158.5 |
| 1 year | 99.5 | | 158.5 |
| 3 years | 64.2 | | 158.5 |
| 5 years | 64.2 | | 255.4 |
| 10 years | 47.36 | | 255.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Iqbal Ahmed
CEO | Chief Executive Officer | - | 2024-03-03 |
| Director of Finance/CFO | 63 | 2002-12-31 | |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 2009-06-18 | |
| Director/Board Member | - | 2010-01-31 | |
Iqbal Ahmed
BRD | Director/Board Member | - | 1984-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.58% | +1.96% | +33.30% | +3.21% | 544M | |
| -0.53% | -3.95% | +50.70% | +152.78% | 1,024B | |
| +0.21% | -2.68% | +53.20% | +50.87% | 618B | |
| -2.51% | -3.25% | +28.54% | +67.99% | 443B | |
| +0.90% | -0.64% | +40.31% | +34.03% | 349B | |
| -0.06% | -1.38% | +34.00% | +42.31% | 297B | |
| -6.13% | -7.85% | +6.65% | +8.95% | 264B | |
| -0.20% | -6.34% | -2.30% | -43.02% | 209B | |
| -0.64% | +2.43% | +29.74% | +67.16% | 208B | |
| -0.82% | +0.70% | +15.05% | +72.05% | 162B | |
| Average | -0.72% | -1.02% | +28.92% | +45.63% | 357.43B | |
| Weighted average by Cap. | -0.88% | -2.17% | +36.80% | +73.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 54.78B 443M 385M 358M 329M 621M 42.27B 631M 4.22B 1.66B 21.05B 1.66B 1.63B 70.57B | 60.95B 493M 428M 399M 366M 691M 47.03B 702M 4.7B 1.84B 23.42B 1.85B 1.81B 78.52B |
| Net income | 8.66B 70.02M 60.87M 56.65M 52.02M 98.23M 6.68B 99.75M 668M 262M 3.33B 263M 257M 11.16B | 9.52B 76.99M 66.92M 62.29M 57.19M 108M 7.35B 110M 734M 288M 3.66B 289M 283M 12.27B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-30 | BDT 150.90 | +2.58% | 1,582,078 |
| 26-07-29 | BDT 147.10 | -1.08% | 1,019,242 |
| 26-07-28 | BDT 148.70 | +1.09% | 652,400 |
| 26-07-27 | BDT 147.10 | -0.61% | 394,612 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BXPHARMA Stock
Select your edition
All financial news and data tailored to specific country editions
